Table 1.
Clinicopathological characteristics of patients with breast cancer
| Characteristics | No. of cases (%) |
|---|---|
| Age (year) | |
| ≤ 45 | 188 (44.5) |
| > 45 | 234 (55.5) |
| T classification | |
| T1–2 | 371 (87.9) |
| T3–4 | 37 (8.8) |
| N classification | |
| N0 | 203 (48.1) |
| N1–2 | 166 (39.3) |
| N3 | 53 (12.6) |
| ER | |
| Positive | 129 (30.6) |
| Negative | 293 (69.4) |
| PR | |
| Positive | 125 (29.6) |
| Negative | 297 (70.4) |
| Her‐2 receptor | |
| Amplification | 59 (14.0) |
| Nonamplification | 344 (81.5) |
| 2+ | 19 (4.5) |
| Triple‐negative breast cancer | |
| Yes | 238 (56.4) |
| No | 184 (43.6) |
| Vital status (at follow‐up) | |
| Alive | 324 (76.8) |
| Dead | 98 (23.2) |
| Relapse status | |
| Relapse | 110 (26.1) |
| Relapse‐free | 312 (73.9) |
| Menopause status | |
| Premenopausal | 238 (56.4) |
| Menopausal | 184 (43.6) |
| Expression of ANP32E | |
| Low expression | 240 (56.9) |
| High expression | 182 (43.1) |